✦ LIBER ✦

I. Demonstration and purification of an endogenous benzodiazepine from the mammalian brain with a monoclonal antibody to benzodiazepines

✍ Scribed by Angel L. De Blas; Lakshmi Sangameswaran

Book ID: 118341753
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 817 KB
Volume: 39
Category: Article
ISSN: 0024-3205
DOI: 10.1016/0024-3205(86)90316-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and validation of immunoassa

Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4

✍ Renée I. Shapiro; Tatiana Plavina; Brian R. Schlain; R. Blake Pepinsky; Ellen A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 654 KB

A Monoclonal Antibody That Reacts Immuno

A Monoclonal Antibody That Reacts Immunohistochemically with Amyloid Deposits in the Brain Tissue of Alzheimer Patients Binds to an Epitope Present on Complement Factor 4

✍ B. McDonald; M. M. Esiri; R. A. J. McIlhinney 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

197 A phase I and pharmacokinetic (PK) s

197 A phase I and pharmacokinetic (PK) study of an agonistic, fully human monoclonal antibody, HGS-ETR2, to the TNF-alpha related apoptosis inducing ligand receptor 2 (TRAIL R2) in patients with advanced cancer

✍ J. de Bono; G. Attard; R. Plummer; S. Pacey; C. Bale; L. Vidal; A. Greystoke; N. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB

A phase I pharmacokinetic (PK) and seria

A phase I pharmacokinetic (PK) and serial tumor and skin pharmacodynamic (PD) study of weekly, every 2 weeks or every 3 weeks 1-hour (h) infusion EMD72000, an humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients (p) with advanced tumors known to overexpress the EGFR

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Blocking of interleukin 2 (IL 2) binding

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18

✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been